KN Q3 deep dive: demand surge drives capacity expansion and margin opportunity
KN reported Q3 revenue of $184M, beating estimates by 6.9%, with adjusted EPS of $0.38. Q4 guidance exceeds estimates. Strong demand in Precision Devices and MedTech segments drove growth, with capacity expansion planned. The company expects margin improvements through automation and pricing. KN repurchased $25M in shares and reduced debt by $15M.



